Amara Luckay

2.2k total citations · 1 hit paper
23 papers, 1.7k citations indexed

About

Amara Luckay is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Amara Luckay has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 12 papers in Infectious Diseases and 9 papers in Epidemiology. Recurrent topics in Amara Luckay's work include HIV Research and Treatment (14 papers), Virology and Viral Diseases (6 papers) and Immune Cell Function and Interaction (6 papers). Amara Luckay is often cited by papers focused on HIV Research and Treatment (14 papers), Virology and Viral Diseases (6 papers) and Immune Cell Function and Interaction (6 papers). Amara Luckay collaborates with scholars based in United States, Nigeria and Canada. Amara Luckay's co-authors include Preston A. Marx, Cecilia Cheng‐Mayer, Dennis R. Burton, Paul W.H.I. Parren, John P. Moore, Ann J. Hessell, Janet M. Harouse, David C. Montefiori, Douglas F. Nixon and Walter J. Moretto and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Journal of Virology.

In The Last Decade

Amara Luckay

22 papers receiving 1.7k citations

Hit Papers

Antibody Protects Macaques against Vaginal Challenge with... 2001 2026 2009 2017 2001 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro
    2001 530 citations Preston A. Marx, Amara Luckay et al. Journal of Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amara Luckay United States 15 1.1k 818 626 611 315 23 1.7k
Kelly Stefano Cole United States 21 1.2k 1.0× 790 1.0× 762 1.2× 572 0.9× 343 1.1× 50 1.7k
Michael A. Egan United States 25 883 0.8× 850 1.0× 559 0.9× 608 1.0× 510 1.6× 41 1.8k
Meredith Hunter United States 13 1.0k 0.9× 852 1.0× 417 0.7× 433 0.7× 297 0.9× 21 1.6k
M Francotte United States 13 660 0.6× 481 0.6× 514 0.8× 370 0.6× 440 1.4× 20 1.4k
Rajeev Gautam United States 24 1.5k 1.3× 932 1.1× 463 0.7× 717 1.2× 225 0.7× 46 1.8k
Jan McClure United States 19 1.1k 0.9× 483 0.6× 379 0.6× 535 0.9× 293 0.9× 35 1.4k
James T. Fuller United States 17 472 0.4× 893 1.1× 487 0.8× 446 0.7× 457 1.5× 26 1.5k
Vladimír Liška United States 14 1.4k 1.2× 702 0.9× 586 0.9× 570 0.9× 278 0.9× 36 1.6k
Miroslawa Bilska United States 15 1.9k 1.7× 1.0k 1.3× 510 0.8× 810 1.3× 465 1.5× 19 2.1k
Chinglai Yang United States 25 379 0.3× 470 0.6× 945 1.5× 804 1.3× 438 1.4× 46 2.1k

Countries citing papers authored by Amara Luckay

Since Specialization
Citations

This map shows the geographic impact of Amara Luckay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amara Luckay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amara Luckay more than expected).

Fields of papers citing papers by Amara Luckay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amara Luckay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amara Luckay. The network helps show where Amara Luckay may publish in the future.

Co-authorship network of co-authors of Amara Luckay

This figure shows the co-authorship network connecting the top 25 collaborators of Amara Luckay. A scholar is included among the top collaborators of Amara Luckay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amara Luckay. Amara Luckay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leyva-Grado, Victor H., Dominique Promeneur, Krystle N. Agans, et al.. (2024). Establishing an immune correlate of protection for Nipah virus in nonhuman primates. npj Vaccines. 9(1). 244–244.
2.
Matassov, Demetrius, Lisa Evans DeWald, Stefan Hamm, et al.. (2024). Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus. Vaccines. 12(8). 858–858. 3 indexed citations
3.
Leyva-Grado, Victor H., Alexander Marin, Abdul S. Yunus, et al.. (2024). Nano-Assembled Polyphosphazene Delivery System Enables Effective Intranasal Immunization with Nipah Virus Subunit Vaccine. ACS Applied Bio Materials. 7(6). 4133–4141. 3 indexed citations
4.
Clarke, David K., Rong Xu, Demetrius Matassov, et al.. (2020). Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial. The Lancet Infectious Diseases. 20(4). 455–466. 23 indexed citations
5.
Cross, Robert W., Rong Xu, Demetrius Matassov, et al.. (2019). Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death. Journal of Clinical Investigation. 130(1). 539–551. 54 indexed citations
6.
Suksanpaisan, Lukkana, Rong Xu, Mulu Z. Tesfay, et al.. (2018). Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers. Molecular Therapy — Oncolytics. 10. 1–13. 9 indexed citations
7.
8.
Curtis, Kelly A., Melanie S. Kennedy, Amara Luckay, et al.. (2011). Delayed Maturation of Antibody Avidity but Not Seroconversion in Rhesus Macaques Infected With Simian HIV During Oral Pre-Exposure Prophylaxis. JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(5). 355–362. 24 indexed citations
9.
Olson, Matthew W., Amar S. Prashad, Geraldine Bebernitz, et al.. (2009). Small molecule inhibitors of HIV RT Ribonuclease H. Bioorganic & Medicinal Chemistry Letters. 20(1). 398–402. 20 indexed citations
10.
Megati, Shakuntala, Vidia Roopchand, Rong Xu, et al.. (2008). Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses. Vaccine. 26(40). 5083–5094. 14 indexed citations
11.
Xu, Rong, Shakuntala Megati, Vidia Roopchand, et al.. (2008). Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines. Vaccine. 26(37). 4819–4829. 54 indexed citations
12.
13.
Luckay, Amara, Maninder K. Sidhu, Rune Kjeken, et al.. (2007). Effect of Plasmid DNA Vaccine Design and In Vivo Electroporation on the Resulting Vaccine-Specific Immune Responses in Rhesus Macaques. Journal of Virology. 81(10). 5257–5269. 154 indexed citations
14.
Egan, Michael A., Shakuntala Megati, Vidia Roopchand, et al.. (2005). Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice. Vaccine. 24(21). 4510–4523. 25 indexed citations
15.
Ling, Binhua, Ronald S. Veazey, Amara Luckay, et al.. (2002). SIVmac pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. AIDS. 16(11). 1489–1496. 194 indexed citations
16.
Shacklett, Barbara L., Binhua Ling, Ronald S. Veazey, et al.. (2002). Boosting of SIV-Specific T Cell Responses in Rhesus Macaques That Resist Repeated Intravaginal Challenge with SIVmac251. AIDS Research and Human Retroviruses. 18(14). 1081–1088. 4 indexed citations
17.
Chakrabarti, Lisa A., Amara Luckay, & Preston A. Marx. (2001). A Divergent Simian Immunodeficiency Virus from Sooty Mangabey with an Atypical Tat–TAR Structure. AIDS Research and Human Retroviruses. 17(12). 1155–1165. 7 indexed citations
18.
Rose, Nina F., Preston A. Marx, Amara Luckay, et al.. (2001). An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants. Cell. 106(5). 539–549. 381 indexed citations
19.
Chakrabarti, Lisa A., Sharon R. Lewin, Linqi Zhang, et al.. (2000). Age‐dependent changes in T cell homeostasis and SIV load in sooty mangabeys. Journal of Medical Primatology. 29(3-4). 158–165. 21 indexed citations
20.
Chakrabarti, Lisa A., Sharon R. Lewin, Linqi Zhang, et al.. (2000). Normal T-Cell Turnover in Sooty Mangabeys Harboring Active Simian Immunodeficiency Virus Infection. Journal of Virology. 74(3). 1209–1223. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelly Stefano Cole Breakdown of academic impact, for papers by Michael A. Egan Breakdown of academic impact, for papers by Meredith Hunter Breakdown of academic impact, for papers by M Francotte Breakdown of academic impact, for papers by Rajeev Gautam Breakdown of academic impact, for papers by Jan McClure Breakdown of academic impact, for papers by James T. Fuller Breakdown of academic impact, for papers by Vladimír Liška Breakdown of academic impact, for papers by Miroslawa Bilska Breakdown of academic impact, for papers by Chinglai Yang
Rankless by CCL
2026